A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
NCT07109726 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Terremoto Biosciences Inc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Terremoto Biosciences Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Terremoto Biosciences Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Terremoto Biosciences Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Terremoto Biosciences Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.